A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

NCT06788639 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukemia (CLL)
Small Lymphocytic Lymphoma (SLL)

Interventions

BIOLOGICAL: Lisocabtagene maraleucel

Sponsor

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company